Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
J Infect Dis. 2023 Oct 18;228(Suppl 6):S359-S375. doi: 10.1093/infdis/jiac266.
Lassa virus (LASV), Junin virus (JUNV), and several other members of the Arenaviridae family are capable of zoonotic transfer to humans and induction of severe viral hemorrhagic fevers. Despite the importance of arenaviruses as potential pandemic pathogens, numerous gaps exist in scientific knowledge pertaining to this diverse family, including gaps in understanding replication, immunosuppression, receptor usage, and elicitation of neutralizing antibody responses, that in turn complicates development of medical countermeasures. A further challenge to the development of medical countermeasures for arenaviruses is the requirement for use of animal models at high levels of biocontainment, where each model has distinct advantages and limitations depending on, availability of space, animals species-specific reagents, and most importantly the ability of the model to faithfully recapitulate human disease. Designation of LASV and JUNV as prototype pathogens can facilitate progress in addressing the public health challenges posed by members of this important virus family.
拉萨病毒(LASV)、胡宁病毒(JUNV)和沙粒病毒科的其他几个成员能够在动物和人类之间发生转移,并引发严重的病毒性出血热。尽管沙粒病毒作为潜在的大流行病原体具有重要意义,但在该多样化家族的科学知识方面仍存在许多空白,包括对复制、免疫抑制、受体使用以及中和抗体反应的诱导等方面的理解存在空白,这反过来又使医疗对策的开发变得复杂。沙粒病毒医疗对策开发的另一个挑战是需要在高生物安全水平下使用动物模型,根据空间可用性、动物物种特异性试剂,以及最重要的是模型是否能够忠实地再现人类疾病的能力,每种模型都有其独特的优势和局限性。将 LASV 和 JUNV 指定为原型病原体可以促进解决该重要病毒家族成员所带来的公共卫生挑战的进展。